Anistreplase

Anistreplase is a thrombolytic drug. It is also known as anisoylated plasminogen streptokinase activator complex (APSAC). As a thrombolytic drug, it is used to treat blood clots in emergency situations.

Anistreplase

Clinical data
Trade names	Eminase
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	B01AD03 (WHO)
Pharmacokinetic data
Elimination half-life	90 minutes
Identifiers
CAS Number	81669-57-0 Y
DrugBank	DB00029 Y
ChemSpider	none
UNII	5O8V541HJ6
KEGG	D02947 Y
Chemical and physical data
Molar mass	approx. 131 kg/mol
(verify)

Uses

Anistreplase is used to treat blood clots in emergency situations such as myocardial infarction.^[1] Early treatment gives better outcomes.^[1]

History

Anistreplase has been developed by Beecham under the brand name Eminase. It is also known as anisoylated plasminogen streptokinase activator complex (APSAC) after its components.^[1][2][3]